Pancreatic DiseasesLast update of the site: Wednesday July 17, 2024
Matthew J.
Townsend
et al. | Alimentary Pharmacology & Therapeutics...
The use of immune checkpoint inhibitors (ICIs) has made a substantial impact in the treatment of numerous advanced malignancies. ICIs are monoclonal antibodies...
Edgar Julián
Rojas-Victoria
et al. | Expert Review of Gastroenterology ...
To determine the effectiveness of the different pharmacological agents in preventing post-ERCP acute pancreatitis We included clinical trials of pharmacological...
Takeshi Ogura et al. | Digestive Diseases and Sciences 2024;...
A novel stent delivery system with a dilation function has recently become available [1, 2] (Fig. 1). Here, we describe technical tips for performing...
Bibliographical searchFocus and target to your research of scientific data
Top articlesThe 5 most read articles
Matthew J.
Townsend
et al. | Alimentary Pharmacology & Therapeutics...
The use of immune checkpoint inhibitors (ICIs) has made a substantial impact in the treatment of numerous advanced malignancies. ICIs are monoclonal antibodies which block the immune “checkpoint”...
Kenta
Yoshida
et al. | Journal of Hepato-Biliary-Pancreatic...
Pancreatic duct stents can be difficult to retrieve because of proximal migration or tearing. We describe a case of successful endoscopic retrieval of the transmural pancreatic stent by “pushing...
Tsukita Hikaru et al. | Diagnostic Pathology 2024; 19(1): 59...
A PEComa is a mesenchymal neoplasm composed of perivascular epithelioid cells that occurs in the uterus, soft tissues, and other organs [1]. It is also a general term used for tumors of perivascular epithelioid...
Han‐Yun
Wang
et al. | Advances in Digestive Medicine 2024;...
TTP is one of the unique causes of thrombotic microangiopathies (TMA), clinically presenting with thrombocytopenia, hemolytic anemia, neurological symptoms, fever, and renal impairment. It may also involve...
Edgar Julián
Rojas-Victoria
et al. | Expert Review of Gastroenterology ...
To determine the effectiveness of the different pharmacological agents in preventing post-ERCP acute pancreatitis We included clinical trials of pharmacological interventions for prophylaxis of acute post-ERCP...
Communicate!
You find this service useful for your professional practice? Inform a colleague about the platform.